GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (LSE:SCLP) » Definitions » Total Inventories

Scancell Holdings (LSE:SCLP) Total Inventories : £0.00 Mil (As of Oct. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Scancell Holdings Total Inventories?

Scancell Holdings's total inventories for the quarter that ended in Oct. 2023 was £0.00 Mil. Scancell Holdings's average total inventories from the quarter that ended in Apr. 2023 to the quarter that ended in Oct. 2023 was £0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Scancell Holdings's Net-Net Working Capital per share for the quarter that ended in Oct. 2023 was £-0.02.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Scancell Holdings Total Inventories Historical Data

The historical data trend for Scancell Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings Total Inventories Chart

Scancell Holdings Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Scancell Holdings Semi-Annual Data
Apr14 Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Scancell Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Scancell Holdings  (LSE:SCLP) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Scancell Holdings's Net-Net Working Capital Per Share for the quarter that ended in Oct. 2023 is

Net-Net Working Capital Per Share (Q: Oct. 2023 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(13.079+0.75 * 0.476+0.5 * 0-30.615
-0-0)/819.982
=-0.02

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Scancell Holdings's Days Inventory for the six months ended in Oct. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Oct. 2023 )/Cost of Goods Sold (Q: Oct. 2023 )*Days in Period
=0/0*365 / 2
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Scancell Holdings's Inventory Turnover for the quarter that ended in Oct. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Oct. 2023 ) / Average Total Inventories (Q: Oct. 2023 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Scancell Holdings's Inventory to Revenue for the quarter that ended in Oct. 2023 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Oct. 2023 ) / Revenue (Q: Oct. 2023 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Scancell Holdings Total Inventories Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Scancell Holdings (LSE:SCLP) Business Description

Traded in Other Exchanges
Address
Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (LSE:SCLP) Headlines

No Headlines